New advances in drug therapy of chronic hepatitis B infection / 中华临床感染病杂志
Chinese Journal of Clinical Infectious Diseases
;
(6): 393-400, 2019.
Artigo
em Chinês
| WPRIM
| ID: wpr-791605
ABSTRACT
Nucleos( t) ide analogs and interferon are currently the main drugs for the treatment of chronic hepatitis B; they can induce sustained virologic suppression of HBV DNA , but still can’t clear HBsAg effectively.With the further understanding of the biology and life cycle of HBV and the breakthrough of direct antiviral agent for HCV treatment , multiple new drugs aiming at "cure HBV"and clear HBsAg are undergoing preclinical development and /or clinical trials.This article reviews the latest advances in drug therapy of chronic hepatitis B infection.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Clinical Infectious Diseases
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS